EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Gland Pharma (GLAND IN) India

Healthcare

Smart Insider

M N Ravi Chandra (VP of Operations since 2004) sold 5,000 shares at INR 1,730, cutting his stake by 50%. This is only his second sale, and whilst smaller in size than his prior timely sale of 7,000 shares in Aug 21 at INR 4,035, it is concerning to see him selling at less than half the price. K V G K Raju (CTO since 2021) sold 7,992 shares at INR 1,790, reducing his holding to zero. There is no news that he is leaving. Moreover, P Balaji (Head of Logistics) sold 1,000 shares at INR 1,764, cutting his holdings in half at the lowest price he has sold shares. This is a concerning cluster of sales from key officers and all have good overall records as sellers.

Edition: 182

- 22 March, 2024